Signal transduction mechanisms within the entorhinal cortex that support latent inhibition of cued fear conditioning

Neurobiology of Learning and Memory

Volumn 88, Issue 3, 2007, Pages 359-368

  Lewis, Michael C ^a   Gould, Thomas J ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Attention; Fear conditioning; Latent inhibition; Learning; MAPK; NMDA; PKA

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; ENTORHINAL CORTEX; FEAR; LATENT INHIBITION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; CONDITIONING, CLASSICAL; CUES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENTORHINAL CORTEX; FEAR; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURAL INHIBITION; PRACTICE (PSYCHOLOGY); RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOGNITION (PSYCHOLOGY); SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 34548237492     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2007.04.011     Document Type: Article

References (52)

1. Abel T., Nguyen P.V., Barad M., Deuel T.A., Kandel E.R., and Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88 (1997) 615-626
2. Atkins C.M., Selcher J.C., Petraitis J.J., Trzaskos J.M., and Sweatt J.D. The MAPK cascade is required for mammalian associative learning. Nature Neuroscience 1 (1998) 602-609
3. Barad M., Bourtchouladze R., Winder D.G., Golan H., and Kandel E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proceedings of the National Academy of Sciences 95 (1998) 15020-15025
4. Chwang W.B., O'Riordan K.J., Levenson J.M., and Sweatt J.D. ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learning and Memory 13 (2006) 322-328
5. Coutureau E., Galani R., Gosselin O., Majchrzak M., and Di Scala G. Entorhinal but not hippocampal or subicular lesions disrupt latent inhibition in rats. Neurobiology of Learning and Memory 72 (1999) 143-157
6. Coutureau E., Gosselin O., and Di Scala G. Restoration of latent inhibition by olanzapine but not haloperidol in entorhinal cortex-lesioned rats. Psychopharmacology 150 (2000) 226-232
7. Coutureau E., Lena I., Dauge V., and Di S.G. The entorhinal cortex-nucleus accumbens pathway and latent inhibition: A behavioral and neurochemical study in rats. Behavioral Neuroscience 116 (2002) 95-104
8. Davis J.A., and Gould T.J. Rolipram attenuates MK-801-induced deficits in latent inhibition. Behavioral Neuroscience 119 (2005) 595-602
9. Fanselow M.S., Kim J.J., Yipp J., and De Oca B. Differential effects of the N-methyl-d-aspartate antagonist DL-2-amino-5-phosphonovalerate on acquisition of fear of auditory and contextual cues. Behavioral Neuroscience 108 (1994) 235-240
10. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. Journal of Biological Chemistry 273 (1998) 18623-18632
11. Fischer A., Sananbenesi F., Schrick C., Spiess J., and Radulovic J. Distinct roles of hippocampal de novo protein synthesis and actin rearrangement in extinction of contextual fear. Journal of Neuroscience 24 (2004) 1962-1966
12. Gould T.J., Collins A.C., and Wehner J.M. Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition. Nicotine and Tobacco Research 1 (2001) 17-24
13. Gould T.J., and Lewis M.C. Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning. Learning and Memory 12 (2005) 389-398
14. Gould T.J., and Wehner J.M. Genetic influences on latent inhibition. Behavioral Neuroscience 113 (1999) 1291-1296
15. Holahan M.R., and Routtenberg A. Post-translational synaptic protein modification as substrate for long-lasting, remote memory: An initial test. Hippocampus 17 (2007) 93-97
16. Jeanblanc J., Peterschmitt Y., Hoeltzel A., and Louilot A. Influence of the entorhinal cortex on accumbal and striatal dopaminergic responses in a latent inhibition paradigm. Neuroscience 128 (2004) 187-200
17. Kim J.J., DeCola J.P., Landeira-Fernandez J., and Fanselow M.S. N-methyl-d-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behavioral Neuroscience 105 (1991) 126-133
18. Kim J.J., Fanselow M.S., DeCola J.P., and Landeira-Fernandez J. Selective impairment of long-term but not short-term conditional fear by the N-methyl-d-aspartate antagonist APV. Behavioral Neuroscience 106 (1992) 591-596
19. Lattal K.M., and Abel T. Different requirements for protein synthesis in acquisition and extinction of spatial preferences and context-evoked fear. Journal of Neuroscience 21 (2001) 5773-5780
20. Lattal K.M., Radulovic J., and Lukowiak K. Extinction: Does it or doesn't it? The requirement of altered gene activity and new protein synthesis. Biological Psychiatry 60 (2006) 344-351
21. LeDoux J.E., Iwata J., Cicchetti P., and Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. Journal of Neuroscience 8 (1988) 2517-2529
22. Levenson J.M., O'Riordan K.J., Brown K.D., Trinh M.A., Molfese D.L., and Sweatt J.D. Regulation of histone acetylation during memory formation in the hippocampus. Journal of Biological Chemistry 279 (2004) 40545-40559
23. Lewis M.C., Davis J.A., and Gould T.J. Inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase disrupts latent inhibition of cued fear conditioning in C57BL/6 mice. Behavioral Neuroscience 118 (2004) 1444-1449
24. Lewis M.C., and Gould T.J. Latent inhibition of cued fear conditioning: An NMDA receptor-dependent process that can be established in the presence of anisomycin. European Journal of Neuroscience 20 (2004) 818-826
25. Lewis M.C., and Gould T.J. Reversible inactivation of the entorhinal cortex disrupts the establishment and expression of latent inhibition of cued fear conditioning in C57BL/6 mice. Hippocampus 17 (2007) 462-470
26. Lubow R.E. Latent inhibition and conditioned attention theory (1989), Cambridge University Press, New York
27. Maren S. Synaptic mechanisms of associative memory in the amygdala. Neuron 47 (2005) 783-786
28. Martin J.H. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neuroscience Letters 127 (1991) 160-164
29. McDonald A.J., and Mascagni F. Projections of the lateral entorhinal cortex to the amygdala: A Phaseolus vulgaris leucoagglutinin study in the rat. Neuroscience 77 (1997) 445-459
30. Quinlan E.M., and Halpain S. Emergence of activity-dependent, bidirectional control of microtubule-associated protein MAP2 phosphorylation during postnatal development. Journal of Neuroscience 16 (1996) 7627-7637
31. Roberson E.D., English J.D., Adams J.P., Selcher J.C., Kondratick C., and Sweatt J.D. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. Journal of Neuroscience 19 (1999) 4337-4348
32. Rothermel J.D., and Parker Botelho L.H. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3′,5′-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochemical Journal 251 (1988) 757-762
33. Routtenberg A., and Rekart J.L. Post-translational protein modification as the substrate for long-lasting memory. Trends in Neurosciences 28 (2005) 12-19
34. Royer S., Martina M., and Pare D. An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. Journal of Neuroscience 19 (1999) 10575-10583
35. Sananbenesi F., Fischer A., Schrick C., Spiess J., and Radulovic J. Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: A possible link between stress and fear memory. Journal of Neuroscience 23 (2003) 11436-11443
36. Schafe G.E., Atkins C.M., Swank M.W., Bauer E.P., Sweatt J.D., and LeDoux J.E. Activation of ERK/MAP kinase in the amygdala is required for memory of pavlovian fear conditioning. Journal of Neuroscience 20 (2000) 8177-8187
37. Schafe G.E., and LeDoux J.E. Memory consolidation of auditory pavlovian fear conditioning requires protein synthesis and protein kinase A in the amygdala. Journal of Neuroscience 20 (2000) RC 96
38. Schauz C., and Koch M. Blockade of NMDA receptors in the amygdala prevents latent inhibition of fear-conditioning. Learning and Memory 7 (2000) 393-399
39. Schenberg E.E., Soares J.C., and Oliveira M.G. Effects of pre- or post-training entorhinal cortex AP5 injection on fear conditioning. Physiology and Behavior 86 (2005) 508-515
40. Seillier A., Dieu Y., Herbeaux K., Di Scala G., Will B., and Majchrzak M. Evidence for a critical role of entorhinal cortex at pre-exposure for latent inhibition disruption in rats. Hippocampus 17 (2007) 220-226
41. Selcher J.C., Weeber E.J., Varga A.W., Sweatt J.D., and Swank M. Protein kinase signal transduction cascades in mammalian associative conditioning. Neuroscientist 8 (2002) 122-131
42. Sewards T.V., and Sewards M.A. Input and output stations of the entrohinal cortex: Superficial vs. deep layers or lateral vs. medial divisions?. Brain Research Reviews 42 (2003) 243-251
43. Shadach E., Feldon J., and Weiner I. Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: Implications for the mechanism of action of antipsychotic drugs. International Journal of Neuropsychopharmacology 2 (1999) 283-291
44. Sweatt J.D. The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory. Journal of Neurochemistry 76 (2001) 1-10
45. Traverso L.M., Ruiz G., and De la Casa L.G. Latent inhibition disruption by MK-801 in a conditioned taste-aversion paradigm. Neurobiology of Learning and Memory 80 (2003) 140-146
46. Watkins J.C., and Evans R.H. Excitatory amino acid transmitters. Annual Review of Pharmacology and Toxicology 21 (1981) 165-204
47. Weiner I. The "two-headed" latent inhibition model of schizophrenia: Modeling positive and negative symptoms and their treatment. Psychopharmacology 169 (2003) 257-297
48. Weiner I., Schiller D., Gaisler-Salomon I., Green A., and Joel D. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behavioral Pharmacology 14 (2003) 215-222
49. Wood M.A., Hawk J.D., and Abel T. Combinatorial chromatin modifications and memory storage: A code for memory?. Learning and Memory 13 (2006) 241-244
50. Young A.M., Moran P.M., and Joseph M.H. The role of dopamine in conditioning and latent inhibition: What, when, where and how?. Neuroscience and Biobehavioral Reviews 29 (2005) 963-976
51. Zhang H.T., Crissman A.M., Dorairaj N.R., Chandler L.J., and O'Donnell J.M. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology 23 (2000) 198-204
52. Zukerman L., and Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. Journal of Research 39 (2005) 311-323